Data / Drug companies / Calcium chloride
Calcium chloride: 14 companies and 18 products in the FDA NDC directory
Calcium chloride is listed in the FDA National Drug Code Directory by 14 companies, with 18 products in commercial distribution. 12 of the products (66.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, and the newest product started marketing on October 12, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 18
- Generic (ANDA) products
- 12 (66.7%)
- Application numbers
- 6
- Routes
- Intravenous, Intraventricular
- openFDA record search
- api.fda.gov
Companies that list calcium chloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | 3 | injection, solution; injection | Generic drugs (ANDA) | July 10, 2020 |
| Amneal Pharmaceuticals LLC | 2 | injection, solution | Generic drugs (ANDA) | July 17, 2024 |
| Medical Purchasing Solutions, LLC | 2 | injection, solution; injection | New drug applications (NDA) | September 14, 2005 |
| American Regent, Inc. | 1 | injection, solution | Generic drugs (ANDA) | February 6, 2018 |
| Civica, Inc. | 1 | injection, solution | Generic drugs (ANDA) | April 2, 2021 |
| Dr. Reddy's Laboratories Inc. | 1 | injection, solution | Generic drugs (ANDA) | January 20, 2025 |
| Eskayef Pharmaceuticals Limited | 1 | injection, solution | Generic drugs (ANDA) | September 10, 2026 |
| Henry Schein, Inc. | 1 | injection, solution | New drug applications (NDA) | January 9, 2022 |
| Hospira, Inc. | 1 | injection, solution | New drug applications (NDA) | September 14, 2005 |
| International Medication Systems, Limited | 1 | injection | Generic drugs (ANDA) | July 8, 2018 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | injection, solution | Generic drugs (ANDA) | October 12, 2026 |
| ProPharma Distribution | 1 | injection | Generic drugs (ANDA) | July 8, 2018 |
| Remedyrepack Inc. | 1 | injection | Generic drugs (ANDA) | September 24, 2024 |
| Square Pharmaceuticals Limited | 1 | injection, solution | Generic drugs (ANDA) | January 15, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 13 | 72.2% |
| Injection | 5 | 27.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 12 | 66.7% |
| New drug applications (NDA) | 4 | 22.2% |
| Other unapproved drugs | 2 | 11.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Blood Coagulation Factor | 18 |
| Phosphate Binder | 18 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.